ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,918Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 162

$701K Total Retail Price of All Prescriptions

Rank: 9 out of 162

197 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 197 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

15% of this provider’s 197 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 7,789 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 60%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $176 among peers.

Prescriptions per Patient

50 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
WARFARIN SODIUM 977 952 1 11
SIMVASTATIN 344 285 2 9
DONEPEZIL HCL 262 250 3 25
FUROSEMIDE 260 213 4 7
AMLODIPINE BESYLATE 248 211 5 12
POTASSIUM CHLORIDE 219 173 6 22
MIRTAZAPINE 207 187 7 40
NAMENDA 190 190 8 47
METOPROLOL TARTRATE 182 132 9 20
LISINOPRIL 177 142 10 14
QUETIAPINE FUMARATE 163 107 11 43
LANTUS 153 101 12 45
CITALOPRAM HBR 153 129 12 39
HYDROCODONE-ACETAMINOPHEN 144 119 S3 14 19
CYMBALTA 143 85 15 71
LEVOTHYROXINE SODIUM 140 119 16 18
GABAPENTIN 137 125 17 30
CLONIDINE HCL 126 69 18 56
FENTANYL 115 102 S2 19 82
HUMALOG 105 73 20 64
TRAZODONE HCL 93 54 21 55
LEVETIRACETAM 92 53 22 63
SERTRALINE HCL 90 79 23 48
CLOPIDOGREL 87 78 24 59
RISPERIDONE 86 41 25 65
CARVEDILOL 84 75 26 36
NYSTATIN 81 62 27 75
ALBUTEROL SULFATE 79 78 28 93
HYDRALAZINE HCL 77 49 29 95
TRAMADOL HCL 76 67 30 31
RAMIPRIL 74 74 31 99
SODIUM CHLORIDE 73 68 32 100
LIDODERM 72 66 33 101
TAMSULOSIN HCL 71 51 34 50
SPIRIVA 71 54 34 1
OLANZAPINE 69 69 36 102
ADVAIR DISKUS 68 67 37 2
SEROQUEL 67 49 38 79
LATANOPROST 63 50 39 110
FLUOXETINE HCL 61 40 40 111
ABILIFY 60 46 41 112
LYRICA 58 38 42 116
ISOSORBIDE MONONITRATE ER 56 46 43 119
CEFTRIAXONE 55 51 44 123
PLAVIX 54 50 45 68
LACTULOSE 54 50 45 125
IPRATROPIUM-ALBUTEROL 53 47 47 127
PROMETHAZINE HCL 53 32 R 47 127
ATORVASTATIN CALCIUM 53 51 47 23
DEXTROSE WITH SODIUM CHLORIDE 53 53 47 127
IPRATROPIUM BROMIDE 53 53 47 45
DIVALPROEX SODIUM 52 0 52 132
METOCLOPRAMIDE HCL 50 31 53 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.